A Little Dirt May Be a Good Thing
FRIDAY, Sept. 9 (HealthDay News) -- Good hygiene has saved
millions of lives, protecting people from countless bacterial and
viral infections, according to the U.S. Centers for Disease Control
Narcissists Make Horrible Bosses: Study
FRIDAY, Sept. 9 (HealthDay News) -- Narcissists' too-high
opinion of themselves means they don't make good business or
political leaders, according to a new study.
Health Tip: Managing Diabetic Heart Disease
(HealthDay News) -- The risk of developing diabetic heart
disease (DHD) is directly related to a person's blood sugar level,
the National Heart Lung and Blood Institute says.
When Protecting Baby Becomes an Obsession
THURSDAY, Sept. 8 (HealthDay News) -- Many new mothers feel a
bit anxious about caring for their infant. But sometimes that
concern develops into an obsession over all the things that can go
States Get Creative in Raising Money for Breast Cancer Programs
FRIDAY, Sept. 9 (HealthDay News) -- Fundraising methods such as
a state lottery, selling specialty license plates and offering the
ability to make a donation on state income tax forms have raised
millions of dollars for breast cancer research and prevention
programs in the United States, a new study says.
Risk for COPD Higher Than Thought: Study
THURSDAY, Sept. 8 (HealthDay News) -- People are at much higher
risk for developing chronic obstructive pulmonary disease (COPD)
than previously thought, according to a new study.
New Approach to Treating Asthma in Pregnancy
FRIDAY, Sept. 9 (HealthDay News) -- Researchers in Australia
have developed a new treatment plan to reduce asthma flare-ups in
pregnancy while minimizing drug exposure to developing fetuses.
For Many Americans, 9/11 Worries Still Dominate
FRIDAY, Sept. 9 (HealthDay News) -- Almost half of all the U.S.
adults who experienced physical or psychological problems in the
months following the 9/11 terrorist attacks still struggle with
feelings of fear and anxiety 10 years later, a new
Harris Interactive/HealthDay poll found.
FDA Advisers Call for Revised Labels for Osteoporosis Drugs
FRIDAY, Sept. 9 (HealthDay News) -- U.S. Food and Drug
Administration advisers recommended Friday that osteoporosis drugs
such as Fosamax, Actonel, Boniva and Reclast come with revised
labels, clarifying how long a patient should take a drug before
potential health risks set in.